TLR9 and COVID-19: This TLR9-COVID-19 hypothesis, presented by Bezemer and Garssen, proposes that CpG islands in SARS-CoV-2 or mtDNA released from damaged host cells could trigger TLR9 activation and subsequently elicit pathogenic hyperinflammatory responses.